Concepedia

Andreas von Sprecher

AV

Statistics

Publications

10

Citations

240

H-Index

10

Active since

1981

Affiliations

Novartis (Switzerland)(Current)

The University of Melbourne

Andreas von Sprecher is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyImmunologyMedicinal ChemistryBiochemistryNatural SciencesNeuropharmacologyChemistry

Publications per year

1981–2005

10

Publications

10

The synthesis of pyridine derivatives from 3‐formylchromone

Georges Haas, James L. Stanton, Andreas von Sprecher et al. · Journal of Heterocyclic Chemistry · 1981 · 63 citations

Pyridine Derivatives, Derivative (Chemistry), Derivatives +10

Novel cell-penetrating α-keto-amide calpain inhibitors as potential treatment for muscular dystrophy

Cyrille Lescop, Holger Herzner, H. Siendt et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 37 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +3

Synthesis and SAR of a novel, potent and structurally simple LTD4 antagonist of the quinoline class

Andreas von Sprecher, Marc Gerspacher, A. Beck et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 27 citations · Full text

Medicinal Chemistry, Natural Sciences, Medicine +9

Peptidoleukotriene antagonists: Structural analogs of leukotriene D4 with special emphasis on CGP 45715A

Andreas von Sprecher, A. Beck, A. Sallmann et al. · Drugs of the Future · 1991 · 22 citations

Anti-inflammatory, Biochemistry, Functional Selectivity +10

Dual neurokinin NK1/NK2 receptor antagonists

Marc Gerspacher, Andreas von Sprecher · Drugs of the Future · 1999 · 19 citations

Functional Selectivity, Medicine, Pharmacology +6

1–5 of 10